What does the NIHR Research Activity League Table mean to you?

Where does your trust feature on the league table? View the league table data

Dr Jonathan Sheffield, Chief Executive Officer, NIHR Clinical Research Network


"Another fantastic year for trusts and CCG regions delivering research across England.

The league table is really about giving research opportunities to all patients in the NHS. Listen to patients' stories, of the powerful effect that research has on their lives and I believe we're still only scratching the surface of the potential that the NHS has to deliver for high quality clinical research. In it's 70th Anniversary year, let's make this year even more successful."

Matt Cooper, Business Development and Marketing Director at the NIHR Clinical Research Network

"Another great year for the NHS delivering life sciences research. More than 50,000 patients have participated in more than 1100 commercial research studies which is great news. It's also great news for UK plc as it shows the UK a strong place to deliver life sciences research."


Go to our Key Statistics page to find out more about our performance


Healthcare professionals

Heather Lambert, Consultant Paediatric Nephrologist, Newcastle Upon Tyne Hospitals NHS Foundation Trust talks about the importance of research in the NHS and her message to patients and members of the public.






Creating a successful research culture in the NHS

Professor Steve Robson, Consultant in Fetal Medicine, Newcastle Upon Tyne Hospitals NHS Foundation Trust and Clinical Director at NIHR CRN North East North Cumbria

Steve talks about how Newcastle Upon Tyne NHS Foundation Trust has embedded research into day-to-day care, and how they have stayed top of the NIHR league table for seven years running.

Why is the Research Activity League Table important to patients?

Professor Keith Channon, Director of Research and Development at Oxford University Hospitals NHS Foundation Trust, on his trust's achievement coming top of the table for the number of participants recruited into studies.

Two NIHR Patient Research Ambassadors, Peter and Richard, explain why the NIHR Research Activity League table is important to patients and why it’s important that Trusts and CCG regions continue to offer more opportunities to patients to participate in research.

Peter's view:


Richard's view:

The NIHR Clinical Research Network supports commercial research studies in the NHS. 
Colleagues from UK pharmaceutical organisations, explain why the NIHR is important to them.

Professor Nick Lemoine,  Director of Barts Cancer Institute and NIHR CRN Medical Director, 

Nick describes Barts Health's achievement topping NIHR's league table for commercial research activity for the second year in a row.